Food & Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food & Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Introgen Therapeutics, Inc.
Food, drug law expert joins biopharmaceutical company's board of directors
September 24th, 2004
Introgen Therapeutics, Inc., (INGN) announced the appointment of Peter Barton Hutt to its board of directors. Hutt, former chief counsel for the Food and Drug Administration (FDA), has participated in drafting most major FDA legislation considered by Congress during the past 40 years including the Orphan Drug Act of 1983, the Prescription Drug User Fee Act of 1992, and the Food and Drug Administration Modernization Act of 1997. Hutt is currently a partner in the Washington, D.C. law firm of Covington & Burling specializing in food and drug law. "I have always regarded Introgen as an exciting company with a great future. I look...
Source: Food & Drug Law Weekly (2004-09-24)
|
